Finance

Lists
NRIX:NASDAQ
Nurix Therapeutics Inc
23,34 $
-1,56%
(-0,37) 1D
23,34 $
0,00% (0,00)
After hours
Closed: 1 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRIX...
Open
23,60 $
High
23,98 $
Low
23,21 $
Mkt. cap
2,42 մլրդ
Avg. vol.
1,46 մլն
Volume
1,33 մլն
52-wk high
28,23 $
52-wk low
8,94 $
EPS
-3,45 $
Beta
1,80
Shares outstanding
103,78 մլն
No. of employees
317
Open
23,60 $
High
23,98 $
Low
23,21 $
Mkt. cap
2,42 մլրդ
Avg. vol.
1,46 մլն
Volume
1,33 մլն
52-wk high
28,23 $
52-wk low
8,94 $
EPS
-3,45 $
Beta
1,80
Shares outstanding
103,78 մլն
No. of employees
317
News stories
From web sources and news partners
About Nurix Therapeutics Inc
CEO-
Employees317
Founded2009
HeadquartersBrisbane, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to NRIX in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for NRIX in the last 3 months.
Highest
Current 23,34 $
45,00 $ (+92,80%)
Average
34,50 $ (+47,81%)
Lowest
25,00 $ (+7,11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Archila
Wells Fargo
Hold
Maintained
25,00 $
+7,1%
09/01/2026
Brian Abrahams
RBC Capital
Buy
Reiterated
36,00 $
+54,2%
08/10/2026
Gil Blum
Needham
Buy
Maintained
34,00 $
+45,7%
08/04/2026
Terence Flynn
Morgan Stanley
Buy
Reiterated
38,00 $
+62,8%
07/28/2026
David Dai
UBS
Buy
Reiterated
31,00 $
+32,8%
07/22/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
34,00 $
+45,7%
07/13/2026
Kostas Biliouris
Oppenheimer
Buy
Maintained
28,00 $
+20%
07/10/2026
Nevin Varghese
RBC Capital
Buy
Reiterated
33,00 $
+41,4%
07/09/2026
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
40,00 $
+71,4%
07/10/2026
Gregory Renza
Truist Financial
Buy
Reiterated
34,00 $
+45,7%
07/10/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
34,00 $
+45,7%
07/10/2026
Roger Song
Jefferies
Buy
Maintained
45,00 $
+92,8%
07/08/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
32,00 $
+37,1%
07/01/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
06/11/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
28,00 $
+20%
05/13/2026
Biren Amin
Piper Sandler
Buy
Maintained
35,00 $
+50%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. օգս
2025 թ. նոյ
2026 թ. փտվ
2026 թ. մյս
Revenue
7,89 մլն
13,58 մլն
6,25 մլն
9,04 մլն
Cost of goods sold
86,12 մլն
83,02 մլն
84,14 մլն
87,65 մլն
Cost of revenue
86,12 մլն
83,02 մլն
84,14 մլն
87,65 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,16 մլն
13,65 մլն
14,61 մլն
15,59 մլն
Operating expense
13,16 մլն
13,65 մլն
14,61 մլն
15,59 մլն
Total operating expenses
99,28 մլն
96,67 մլն
98,75 մլն
103,25 մլն
Operating income
-91,38 մլն
-83,10 մլն
-92,50 մլն
-94,20 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-86,42 մլն
-78,22 մլն
-87,17 մլն
-89,81 մլն
EBT excluding unusual items
-86,42 մլն
-78,22 մլն
-87,17 մլն
-89,81 մլն
Income tax expense
-
-
-
-271,00 հզր
Effective tax rate
-
-
-
0,30%
Other operating expenses
-
-
-
-
Net income
-86,42 մլն
-78,22 մլն
-87,17 մլն
-89,54 մլն
Net profit margin
-1 094,77%
-576,13%
-1 394,34%
-990,10%
Earnings per share
-1,03
-0,82
-0,79
-0,81
Interest and investment income
4,96 մլն
4,87 մլն
5,32 մլն
4,40 մլն
Interest expense
-
-
-
-
Net interest expenses
4,96 մլն
4,87 մլն
5,32 մլն
4,40 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-89,36 մլն
-81,58 մլն
-90,30 մլն
-91,95 մլն
Gain or loss from assets sale
-
89,00 հզր
160,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps